Chronotropic incompetence

Last updated
Chronotropic incompetence
Other namesChronotropic intolerance
Symptoms Exercise intolerance
Diagnostic method Cardiopulmonary exercise test
Prevalence50% among people with heart failure

Chronotropic incompetence (CI) is the inability of heart rate to increase as expected in response to exercise. The condition can be defined in different ways and occurs in various diseases. Sufferers have a higher risk of cardiovascular disease and early death.

Contents

Definition

In healthy people, cardiac output during exercise increases via a rise in both heart rate and stroke volume. When the heart rate does not rise sufficiently, this can lead to exercise intolerance. CI can be detected using a cardiopulmonary exercise test. [1] People with CI have a higher risk of cardiovascular disease and early death. [1]

There are different ways to define CI. One common threshold is not being able to reach 80% of age-predicted maximal heart rate (APMHR), which is said to be 220 – age. Another definition is not being able to reach 80% of the expected heart rate reserve, that is, the difference between the individual's resting heart rate and APMHR. [1]

Incidence

Chronotropic incompetence occurs in various diseases. Roughly half of people with heart failure experience it, compared to less than 9% of age-matched healthy controls. [2] When CI occurs alongside issues with stroke volume, it can lead to a strong decrease in functional ability. [1] It is associated with the activation of the sympathetic nervous system (part of the fight-or-flight response), leading to higher levels of norepinephrine. CI in people with heart failure can further be related to the use of β-blockers, a high resting heart rate or the downregulation of β-adrenergic receptors. [3]

CI is also observed in people with obstructive sleep apnea. [4] Similarly to CI in heart failure, it is possibly linked to the autonomic nervous system shift towards the sympathetic nervous system. [1] [4] People with type-2 diabetes often experience CI too, [5] as do some people with long COVID. [6] People with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) also experience a blunted heart rate response to exercise. [7] CI in ME/CFS is most evident on the second day of a repeated exercise test, after the first exercise test induces post-exertional malaise. [8]

Related Research Articles

<span class="mw-page-title-main">Fatigue</span> Range of afflictions, usually associated with physical or mental weakness

Fatigue describes a state of tiredness, exhaustion or loss of energy.

<span class="mw-page-title-main">ME Association</span> UK charitable organization

The ME Association is a UK health charitable organization that provides information, advocacy, and services to persons and families affected by ME/CFS, and raises funds for research into ME/CFS. It has been reported to be one of the two largest UK charities for ME/CFS.

<span class="mw-page-title-main">Exercise intolerance</span> Medical condition

Exercise intolerance is a condition of inability or decreased ability to perform physical exercise at the normally expected level or duration for people of that age, size, sex, and muscle mass. It also includes experiences of unusually severe post-exercise pain, fatigue, nausea, vomiting or other negative effects. Exercise intolerance is not a disease or syndrome in and of itself, but can result from various disorders.

<span class="mw-page-title-main">History of ME/CFS</span> Aspect of medical history

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has a long history with an evolution in medical understanding, diagnoses and social perceptions.

Management of ME/CFS focusses on symptoms management, as no treatments that address the root cause of the illness are available. Pacing, or regulating one's activities to avoid triggering worse symptoms, is the most common management strategy for post-exertional malaise. Clinical management varies widely, with many patients receiving combinations of therapies.

<span class="mw-page-title-main">Controversies related to ME/CFS</span> Controversies and issues related to ME/CFS

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an illness with a history of controversy. Although it is classified as an organic disease, it was historically assumed to be psychosocial, and a minority of medical professionals still hold this view. The pathophysiology of ME/CFS remains unclear, there exists many competing diagnostic criteria, and some proposed treatments are controversial. There is a lack of awareness about the condition, which has led to substantiated accusations of patient neglect and harm.

<span class="mw-page-title-main">Clinical descriptions of ME/CFS</span> Case definitions of the illness

Clinical descriptions of ME/CFS vary. Different groups have produced sets of diagnostic criteria that share many similarities. The biggest differences between criteria are whether post-exertional malaise (PEM) is required, and the number of symptoms needed.

The Lightning Process (LP) is a three-day personal training programme developed and trademarked by British osteopath Phil Parker. It makes unsubstantiated claims to be beneficial for various conditions, including ME/CFS, depression and chronic pain.

Graded exercise therapy (GET) is a programme of physical activity that starts very slowly and gradually increases over time, intended as a treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Most public health bodies, including the CDC and NICE, consider it ineffective, and its safety is disputed. However, GET still enjoys support among a minority of clinicians and organizations.

David Sheffield Bell is an American physician who has done extensive research on the clinical aspects of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He has also conducted evaluations and research in pediatric ME/CFS and written numerous articles about the condition.

<span class="mw-page-title-main">Myalgic encephalomyelitis/chronic fatigue syndrome</span> Chronic medical condition

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious long-term illness. People with ME/CFS experience a profound fatigue that does not go away with rest, sleep issues and problems with memory or concentration. They are able to do much less than before they became ill. Further common symptoms include dizziness, nausea and pain. The hallmark symptom is a worsening of the illness hours to days after minor physical or mental activity. This "crash" can last less than a day to several months.

Rosamund Vallings is a medical doctor, known as one of the leading authorities on Chronic Fatigue Syndrome (ME/CFS) in New Zealand.

<span class="mw-page-title-main">Post-exertional malaise</span> Worsening of symptoms with activity

Post-exertional malaise (PEM), sometimes referred to as post-exertional symptom exacerbation (PESE) or post-exertional neuroimmune exhaustion (PENE), is a worsening of symptoms that occurs after minimal exertion. It is the hallmark symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and common in long COVID and fibromyalgia. PEM is often severe enough to be disabling, and is triggered by ordinary activities that healthy people tolerate. Typically, it begins 12–48 hours after the activity that triggers it, and lasts for days, but this is highly variable and may persist much longer. Management of PEM is symptom-based, and patients are recommended to pace their activities to avoid triggering PEM.

Idiopathic chronic fatigue (ICF) or chronic idiopathic fatigue or insufficient/idiopathic fatigue is a term used for cases of unexplained fatigue that have lasted at least six consecutive months and which do not meet the criteria for Myalgic Encephalomyelitis/chronic fatigue syndrome. Such fatigue is widely understood to have a profound effect on the lives of patients who experience it.

Peter C. Rowe is a physician and academic. A leading researcher in chronic fatigue syndrome, he is Professor of Pediatrics, Sunshine Natural Wellbeing Foundation Professor of Chronic Fatigue and Related Disorders, and Director of the Children's Center Chronic Fatigue Clinic at Johns Hopkins University School of Medicine.

<span class="mw-page-title-main">Maureen Hanson</span> American molecular biologist

Maureen Hanson is an American molecular biologist and Liberty Hyde Bailey Professor in the Department of Molecular Biology and Genetics at Cornell University in Ithaca, New York. She is a joint member of the Section of Plant Biology and Director of the Center for Enervating Neuroimmune Disease. Her research concerns gene expression in chloroplasts and mitochondria, photosynthesis, and the molecular basis of the disease Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

<span class="mw-page-title-main">2-day CPET</span> Medical test for post-exertional malaise

A 2-day CPET is a cardiopulmonary exercise test given on two successive days to measure the effect of post-exertional malaise (PEM) on a patient's ability to exercise. PEM is a cardinal symptom of myalgic encephalomyelitis/chronic fatigue syndrome and is common in long COVID as well.

Andrew Melvin Ramsay (1901–1990) was a British physician, who is known for his research and advocacy on myalgic encephalomyelitis (ME), a chronic disease causing muscle weakness and cognitive dysfunction. Ramsay worked as a consultant at the Royal Free Hospital in London during a mysterious 1955 disease outbreak of what later became known as ME. He studied the disease and similar outbreaks elsewhere. Work by Ramsay showed that although ME seldom caused death, the disease could be highly disabling.

Carmen Scheibenbogen is a German immunologist who is the acting director of the Institute for Medical Immunology of the Charité university hospital in Berlin. She specialises in hematology, oncology and immunology. She leads the Outpatient Clinic for Immunodeficiency and the Fatigue Centre at the Charité hospital. She is one of the few doctors specialised in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Germany, and also researches long COVID.

The PACE trial was a large and controversial trial which compared the effects of cognitive behavioural therapy (CBT), graded exercise therapy (GET), adaptive pacing therapy, and specialist medical care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

References

  1. 1 2 3 4 5 Zweerink A, van der Lingen AC, Handoko ML, van Rossum AC, Allaart CP (August 2018). "Chronotropic Incompetence in Chronic Heart Failure". Circulation. Heart Failure. 11 (8): e004969. doi:10.1161/CIRCHEARTFAILURE.118.004969. PMID   30354566.
  2. Smart NA, Clark H, Brubaker P, Witte KK, Jimil H, Gierula J, Patel HC, Pearson MJ (May 2022). "Effects of chronotropic incompetence on exercise capacity in people with heart failure versus age-matched controls". Heart Failure Reviews. 27 (3): 795–809. doi:10.1007/s10741-021-10081-1. PMID   33871758.
  3. Grosman-Rimon L, Wright E, Sabovich S, Rimon J, Gleitman S, Sudarsky D, Lubovich A, Gabizon I, Lalonde SD, Tsuk S, McDonald MA, Rao V, Gutterman D, Jorde UP, Carasso S, Kachel E (January 2023). "Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients". Heart Failure Reviews. 28 (1): 35–45. doi:10.1007/s10741-022-10232-y. PMID   35325323.
  4. 1 2 Powell, Tyler A.; Mysliwiec, Vincent; Brock, Matthew S.; Morris, Michael J. (2022). "OSA and cardiorespiratory fitness: a review". Journal of Clinical Sleep Medicine. 18 (1): 279–288. doi:10.5664/jcsm.9628. ISSN   1550-9389. PMC   8807904 . PMID   34437054.
  5. Keytsman C, Dendale P, Hansen D (July 2015). "Chronotropic Incompetence During Exercise in Type 2 Diabetes: Aetiology, Assessment Methodology, Prognostic Impact and Therapy". Sports Medicine (Auckland, N.Z.). 45 (7): 985–95. doi:10.1007/s40279-015-0328-5. PMID   25834997.
  6. Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, Grandis DJ, Long CS, Beatty A, Hsue PY (October 2022). "Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis". JAMA Network Open. 5 (10): e2236057. doi:10.1001/jamanetworkopen.2022.36057. PMC   9557896 . PMID   36223120.
  7. Nelson MJ, Bahl JS, Buckley JD, Thomson RL, Davison K (October 2019). "Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis". Medicine. 98 (43): e17600. doi:10.1097/MD.0000000000017600. PMC   6824690 . PMID   31651868.
  8. Davenport TE, Lehnen M, Stevens SR, VanNess JM, Stevens J, Snell CR (2019). "Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?". Frontiers in Pediatrics. 7: 82. doi: 10.3389/fped.2019.00082 . PMC   6439478 . PMID   30968005.